Report Scope & Overview:
Opioid-Induced Constipation (OIC) Treatment Market was valued at $1105.71 million in 2021, and is projected to reach $1785.01 million by 2031, growing at a CAGR of 4.9% from 2022 to 2031.
Global Opioid-Induced Constipation (OIC) Treatment Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Opioid-Induced Constipation (OIC) Treatment Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
The opioid-induced constipation (OIC) treatment market report provides a comprehensive analysis of the global market for medications and therapies aimed at managing constipation caused by opioid usage. OIC refers to a common side effect that occurs in individuals who take opioid medications for pain management. Opioids, which include prescription painkillers like oxycodone and hydrocodone, as well as illegal substances like heroin, can cause severe constipation by slowing down the movement of stool through the digestive system.
The report examines the various factors driving the growth of the OIC treatment market, including the increasing prevalence of chronic pain conditions and the rising use of opioids for pain management. It also considers the impact of regulatory measures and initiatives aimed at addressing the opioid crisis, which have led to heightened awareness and the development of new treatment options for OIC.
Market Segmentations:Global Opioid-Induced Constipation (OIC) Treatment Market: By Company
• GlaxoSmithKline
• AstraZeneca
• Pfizer
• S.L.A. Pharma
• AIKO Biotechnology
• Cubist Pharmaceuticals
• Salix Pharmaceuticals
• Takeda Pharmaceutical
Global Opioid-Induced Constipation (OIC) Treatment Market: By Type
• Oral
• Parenteral (Subcutaneous Injection)
Global Opioid-Induced Constipation (OIC) Treatment Market: By Application
• Drug Store
• Independent Pharmacies
• Hospital Pharmacies
Global Opioid-Induced Constipation (OIC) Treatment Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Opioid-Induced Constipation (OIC) Treatment market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Market Size 2021 | $1105.71 million |
| Market Size 2031 | $1785.01 million |
| Compound Annual Growth Rate (CAGR) | 4.9%(2022-2031) |
| Base Year | 2022 |
| Forecast Period | 2022-2031 |
| Historical Data | 2018-2020 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • Oral • Parenteral (Subcutaneous Injection) |
| By Application | • Drug Store • Independent Pharmacies • Hospital Pharmacies |
| Key Companies Profiled | • GlaxoSmithKline • AstraZeneca • Pfizer • S.L.A. Pharma • AIKO Biotechnology • Cubist Pharmaceuticals • Salix Pharmaceuticals • Takeda Pharmaceutical |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Opioid-Induced Constipation (OIC) Treatment Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of Opioid-Induced Constipation (OIC) Treatment Market Study:
The objectives of Opioid-Induced Constipation (OIC) Treatment market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Opioid-Induced Constipation (OIC) Treatment market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
Opioid-Induced Constipation (OIC) Treatment Market was valued at $1105.71 million in 2021, and is projected to reach $1785.01 million by 2031, growing at a CAGR of 4.9% from 2022 to 2031.
The Opioid-Induced Constipation (OIC) treatment market refers to the market for pharmaceuticals and therapies aimed at managing constipation caused by opioid use. OIC is a common side effect of opioid medications, and this market focuses on products and interventions that help alleviate constipation in individuals taking opioids.
The key factors driving the growth of the OIC treatment market include the increasing use of opioids for pain management, rising awareness about OIC among healthcare professionals and patients, the development of effective treatment options, and the growing demand for improved quality of life among individuals experiencing OIC.
The major treatment options for OIC include laxatives (such as osmotic and stimulant laxatives), prescription medications specifically approved for OIC (such as methylnaltrexone bromide, naloxegol, and naldemedine), probiotics, dietary modifications, and bowel training techniques.
The opportunities in the OIC treatment market include increasing awareness about OIC, research and development efforts to discover more effective treatments, collaborations between pharmaceutical companies and healthcare providers, expansion into emerging markets with a rising incidence of OIC, and integration of technology and digital solutions for improved patient monitoring and engagement.
TABLE OF CONTENT
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Oral
1.2.3 Parenteral (Subcutaneous Injection)
1.3 Market by Application
1.3.1 Global Opioid-Induced Constipation (OIC) Treatment Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Drug Store
1.3.3 Independent Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Perspective (2017-2032)
2.2 Opioid-Induced Constipation (OIC) Treatment Growth Trends by Region
2.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Region (2017-2023)
2.2.3 Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Region (2023-2032)
2.3 Opioid-Induced Constipation (OIC) Treatment Market Dynamics
2.3.1 Opioid-Induced Constipation (OIC) Treatment Industry Trends
2.3.2 Opioid-Induced Constipation (OIC) Treatment Market Drivers
2.3.3 Opioid-Induced Constipation (OIC) Treatment Market Challenges
2.3.4 Opioid-Induced Constipation (OIC) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue
3.1.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue (2017-2023)
3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2017-2023)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue
3.4 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio
3.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid-Induced Constipation (OIC) Treatment Revenue in 2022
3.5 Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Area Served
3.6 Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
3.7 Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Type
4.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Type (2017-2023)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2023-2032)
5 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Application
5.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Application (2017-2023)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2032)
6.2 North America Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2017-2023)
6.4 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2032)
7.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2017-2023)
7.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2032)
8.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2017-2023)
8.4 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2032)
9.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2017-2023)
9.4 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2032)
10.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2017-2023)
10.4 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Introduction
11.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2023)
11.2.5 AstraZeneca Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Introduction
11.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2023)
11.3.5 Pfizer Recent Development
11.4 S.L.A. Pharma
11.4.1 S.L.A. Pharma Company Detail
11.4.2 S.L.A. Pharma Business Overview
11.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Introduction
11.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2023)
11.4.5 S.L.A. Pharma Recent Development
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Detail
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2023)
11.5.5 AIKO Biotechnology Recent Development
11.6 Cubist Pharmaceuticals
11.6.1 Cubist Pharmaceuticals Company Detail
11.6.2 Cubist Pharmaceuticals Business Overview
11.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
11.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2023)
11.6.5 Cubist Pharmaceuticals Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Detail
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
11.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2023)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Detail
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Introduction
11.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2023)
11.8.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast